[144/A] TEVA PHARMACEUTICAL INDUSTRIES LTD SEC Filing

Rhea-AI Filing Summary

TEVA: An amended Form 144 was filed for the proposed sale of 200,000 American Depositary Shares. The filing lists Piper Sandler & Co. as broker, an aggregate market value of $4,920,000, and an approximate sale date of 11/06/2025 on the NYSE.

The shares to be sold were acquired on 05/09/2018. As context, the filing reports 1,147,282,512 shares outstanding. This notice outlines a potential secondary sale by a holder and does not describe any new issuance.

Insights

Capital markets counsel

Amended Form 144 flags a potential secondary sale; neutral impact.

A holder filed a notice to potentially sell 200,000 ADSs with an $4,920,000 aggregate market value through Piper Sandler & Co. on or around 11/06/2025 on the NYSE. The securities were acquired on 05/09/2018.

Form 144 notices are administrative and permit sales under Rule 144 subject to its conditions. Actual sale activity depends on the holder’s decisions and market conditions. The filing also cites 1,147,282,512 shares outstanding as a baseline figure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares(2)	Piper Sandler & Co. 1 Greenwich Plaza Greenwich CT 06830	200000	4920000.00	1147282512	11/06/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	05/09/2018	See Remark 3	See Remark 3			200000	05/09/2018	See Remark 3

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does TEVA’s amended Form 144/A disclose?

A proposed sale of 200,000 American Depositary Shares with an aggregate market value of $4,920,000.

Who is the broker for the planned TEVA ADS sale?

The filing lists Piper Sandler & Co. as the broker.

When is the approximate sale date for the TEVA ADSs?

The notice states an approximate date of 11/06/2025.

On which exchange are the TEVA ADSs expected to be sold?

The filing names the NYSE as the exchange.

How many shares were outstanding according to the notice?

The filing reports 1,147,282,512 shares outstanding.

When were the TEVA ADSs to be sold originally acquired?

The filing lists an acquisition date of 05/09/2018 for 200,000 ADSs.